Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.62
-0.08
(-2.96%)
USD |
NASDAQ |
Oct 30, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Price : 2.62 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.70 | 2.74 | 2.605 | 2.62 | 314785.0 |
| Oct 29, 2026 | 2.81 | 2.948 | 2.69 | 2.70 | 357038.0 |
| Oct 28, 2026 | 2.67 | 2.855 | 2.61 | 2.80 | 482218.0 |
| Oct 27, 2026 | 2.65 | 2.725 | 2.51 | 2.69 | 1.756M |
| Oct 26, 2026 | 2.66 | 2.68 | 2.61 | 2.64 | 483080.0 |
| Oct 23, 2026 | 2.83 | 2.83 | 2.60 | 2.66 | 737352.0 |
| Oct 22, 2026 | 2.66 | 2.85 | 2.66 | 2.85 | 661895.0 |
| Oct 21, 2026 | 2.71 | 2.855 | 2.66 | 2.68 | 942242.0 |
| Oct 20, 2026 | 2.85 | 2.98 | 2.70 | 2.72 | 660932.0 |
| Oct 19, 2026 | 2.84 | 2.90 | 2.79 | 2.85 | 695643.0 |
| Oct 16, 2026 | 2.95 | 2.95 | 2.81 | 2.82 | 480774.0 |
| Oct 15, 2026 | 2.90 | 3.304 | 2.86 | 2.95 | 473894.0 |
| Oct 14, 2026 | 2.94 | 3.07 | 2.88 | 2.905 | 440619.0 |
| Oct 13, 2026 | 3.24 | 3.34 | 2.93 | 2.95 | 505681.0 |
| Oct 12, 2026 | 3.31 | 3.37 | 3.23 | 3.26 | 233972.0 |
| Oct 09, 2026 | 3.43 | 3.50 | 3.295 | 3.31 | 471952.0 |
| Oct 08, 2026 | 3.43 | 3.43 | 3.27 | 3.42 | 566215.0 |
| Oct 07, 2026 | 3.46 | 3.57 | 3.36 | 3.44 | 321385.0 |
| Oct 06, 2026 | 3.60 | 3.72 | 3.48 | 3.50 | 660105.0 |
| Oct 05, 2026 | 3.88 | 3.88 | 3.575 | 3.60 | 481655.0 |
| Oct 02, 2026 | 3.97 | 4.045 | 3.88 | 3.89 | 486002.0 |
| Oct 01, 2026 | 4.05 | 4.10 | 3.82 | 3.94 | 1.364M |
| Sep 30, 2026 | 3.94 | 4.15 | 3.875 | 4.10 | 736320.0 |
| Sep 29, 2026 | 3.83 | 4.02 | 3.80 | 3.92 | 537352.0 |
| Sep 28, 2026 | 3.91 | 3.925 | 3.79 | 3.81 | 476626.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Korsana Biosciences, Inc. | 30.14 |
| IRulya Therapeutics, Inc. | 32.95 |
| PepGen Inc. | 2.36 |
| Q32 Bio, Inc. | 8.91 |
| Arrowhead Pharmaceuticals, Inc. | 59.90 |
Price Related Metrics
| Price to Book Value | 0.6496 |
| Earnings Yield | -47.05K% |
| Market Cap | 209.90M |